comparison of glp-1 agonists short-acting versus long-acting receptor Comparative features of glucagon-like peptide
Description
Zhang B, Cheng Z, Chen J, et al
Real-World Considerations When choosing a GLP-1 medication, doctors and patients must weigh more than just the numbers
This shift in endpoints reflects a broader reframing of obesity as a chronic disease rather than a lifestyle issue
Were doing it because different brand names of the same generic medication have been approved for different indications, so we dont want to cause confusion
Pancreatitis history
